Balyasny Asset Management LLC Aclaris Therapeutics, Inc. Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.01 - $1.36 $14,049 - $18,917	13,910 New	13,910 $15,000
Q3 2023 Nov 14, 2023	BUY	$6.56 - $10.95 $68,952 - $115,095	10,511 New	10,511 $72,000
Q4 2022 Feb 14, 2023	SELL	$14.33 - $18.37 $1.23 Million - $1.57 Million	-85,644 Reduced 80.68%	20,503 $322,000
Q3 2022 Nov 14, 2022	BUY	$13.07 - $18.22 $1.39 Million - $1.93 Million	106,147 New	106,147 $1.67 Million
Q2 2022 Aug 15, 2022	SELL	$10.16 - $17.08 $2.13 Million - $3.58 Million	-209,636 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$9.74 - $17.92 $2.5 Million - $4.6 Million	-256,764 Reduced 55.05%	209,636 $3.61 Million
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.49 $3.74 Million - $5.63 Million	304,557 Added 188.18%	466,400 $6.78 Million
Q3 2021 Nov 15, 2021	BUY	$13.38 - $18.8 $99,319 - $139,552	7,423 Added 4.81%	161,843 $2.91 Million
Q2 2021 Aug 16, 2021	BUY	$17.08 - $29.6 $2.64 Million - $4.57 Million	154,420 New	154,420 $2.71 Million
Q1 2019 May 15, 2019	SELL	$5.63 - $7.84 $1.77 Million - $2.47 Million	-315,167 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$6.3 - $15.4 $1.73 Million - $4.23 Million	-274,833 Reduced 46.58%	315,167 $2.33 Million
Q3 2018 Nov 14, 2018	SELL	$14.38 - $20.89 $1.58 Million - $2.3 Million	-110,111 Reduced 15.73%	590,000 $8.57 Million
Q2 2018 Aug 14, 2018	SELL	$16.46 - $20.33 $4.71 Million - $5.81 Million	-285,865 Reduced 28.99%	700,111 $14 Million
Q1 2018 May 15, 2018	BUY	$17.08 - $25.64 $991,647 - $1.49 Million	58,059 Added 6.26%	985,976 $17.3 Million
Q4 2017 Feb 14, 2018	BUY	$21.47 - $27.8 $9.9 Million - $12.8 Million	461,340 Added 98.88%	927,917 $22.9 Million
Q3 2017 Nov 14, 2017	BUY	$23.02 - $28.8 $10.7 Million - $13.4 Million	466,577	466,577 $12 Million

Others Institutions Holding ACRS

# of Institutions

Shares Held

50.7M

Call Options Held

30.6K

Put Options Held

Bml Capital Management, LLC Zionsville, IN

14.3M
Shares

$41.3 Million
9.64% of portfolio
Vanguard Group Inc Valley Forge, PA

4.69M
Shares

$13.6 Million
0.0% of portfolio
D. E. Shaw & Co., Inc. New York, NY

3.37M
Shares

$9.78 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.01M
Shares

$8.72 Million
0.0% of portfolio
Rock Springs Capital Management LP Baltimore, MD

2.75M
Shares

$7.99 Million
0.11% of portfolio

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $193M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account